Expression and Clinical Significance of Matrix Metalloproteinase-2,9 in Transitional Cell Bladder Carcinoma

YAN Yang,HUANG Guo-hua,XU Yun-fei,ZHANG Hai-min,CHAO Yue-gen,GU Bin

DOI: https://doi.org/10.3969/j.issn.1008-0392.2005.05.022

2005-01-01

Abstract:Objective To investigate the relationship between the expression of matrix metalloproteinase-2,9 (MMP-2,9) and invasion or metastasis of transitional cell bladder carcinoma (TCC). Methods MMP-2,9 gene expressing levels in 43 pairs of TCC tissues and nontumorous bladder tissues were measured by semi-quantitative reverse transcription poly-merase chain reaction (RT-PCR). Results MMP-2 messenger RNA (mRNA) expression was present in 33 of 43 (77%) resected TCCs, whereas it was seen in 9 of 43 (21%) of nontumorous bladder tissues. MMP-9 mRNA expression was present in 23 of 43 (53% ) resected TCCs, whereas it was seen in 11 of 43 (26%) of non-tumorous bladder tissues. The levels of MMP-2,9 mRNA expression in tumors were significantly higher than that in non-tumorous ones (P0.05). In tumors, susceptibility of MMP-2 was superior to MMP-9 (P 0.05). Expression of MMP-2 mRNA was tightly correlated with the expression of MMP-9 mRNA(rs = 0.919, P 0.001). Conclusion Expression of MMP-2,9 correlate closely with the invasion or metastasis of TCC. The result suggests that the expression of MMP-2,9 may be a predictor for poor prognosis of TCC.